NIDA Home > Publications > Research Monographs > | |
Methodological Issues in Epidemiological, Prevention, and Treatment Research on Drug-Exposed Women and Their Children |
|
NIDA Research Monograph, Number 117 [Printed in 1991]If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it. This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph. Table of Contents Preface-----iii Session: ldentifying Research Questions, Designs, and Analyses Methodological Issues in Prevention Research on Drug Use and Pregnancy-----1 Measurement Issues in the Evaluation of Experimental Treatment Interventions-----18 Discussion: Statistical Analysis in Treatment and Prevention Program Evaluation-----31 Session: Quantificatlon of Extent and Duration of Drug Use Role of Biologic Markers in Epidemiologic Studies of Prenatal Drug Exposure: Issues in Study Design-----41 Detection of Prenatal Drug Exposure in the Pregnant Woman and Her Newborn Infant-----61 Methodological Issues in Obtaining and Managing Substance Abuse Information From Prenatal Patients-----80 Discussion: Caveats in Testing for Drugs of Abuse-----98 Session: Subject Selection, Recruitment, and Retention Issues Who Is It Going To Be? Subject Selection Issues in Prenatal Drug Exposure Research-----121 Subject Recruitment and Retention for Longitudinal Research: Practical Considerations for a Nonintervention Model-----137 Subject Recruitment and Retention Issues in Longitudinal Research Involving Substance-Abusing Families: A Clinical Services Context-----155 Perinatal Substance Abuse and AIDS: Subject Selection, Recruitment, and Retention-----166 Discussion: Subject Selection, Recruitment, and Retention in Longitudinal Studies Involving Perinatal Substance Abuse and Human lmmunodeficiency Virus Infection-----183 Session: Measurement Issues Measures of Pregnant, Drug-Abusing Women for Treatment Research-----194 Assessing Acute and Long-Term Physical Effects of In Utero Drug Exposure on the Perinate, Infant, and Child-----212 Methodological Issues in the Assessment of the Mother-Child Interactions of Substance-Abusing Women and Their Children-----228 Discussion: Measurement Issues in the Study of Effects of Substance Abuse in Pregnancy-----248 Session: Research Envlronment Issues Studies of Prenatal Drug Exposure and Environmental Research Issues: The Benefits of Integrating Research Within a Treatment Program-----259 How the Environment Affects Research on Prenatal Drug Exposure: The Laboratory and the Community-----271 Discussion: Research Environment and Use of Multicenter Studies in Perinatal Substance Abuse Research-----293 Session: Intervention Issues Program and Staff Characteristics in Successful Treatment-----305 Process Measures in Interventions for Drug-Abusing Women: From Coping to Competence-----314 Discussion: Dilemmas in Research in Perinatal Addiction-Intervention Issues-----344 Session: Legal Issues In Research With Pregnant Women and Children Alcohol- and Drug-Dependent Pregnant Women: Laws and Public Policies That Promote and Inhibit Research and the Delivery of Services-----349 Mandatory Reporting of Child Abuse and Research on the Effects of Prenatal Drug Exposure-----366 Discussion: Effect of Legal Stipulations on the Conduct of Treatment and Prevention Research-----385 List of NIDA Research Monographs-----394 |
|
Advanced Search | FAQs | Accessibility | Site Map | Help | NIDA Home | Privacy Policy | FOIA (NIH) | Employment | Print Version | ||
The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, September 18, 2002. |